Related Experiment Video
Updated: Apr 4, 2026
08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.8K
One case of inflammatory myofibroblastic tumor--a case report
Chunze Zhang, Chun-Jie Li, Wen-Kang Zong
1Department of Pathology, Tianjin Chest Hospital, Tianjin, China.
Journal of Cancer Research and Therapeutics
|September 2, 2015
Summary
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm. Complete surgical excision is the primary treatment for IMT, which can occur in various body locations.
Area of Science:
- Oncology
- Pathology
Background:
- Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm.
- IMT presents with diverse nomenclature, including inflammatory pseudotumor and plasma cell granuloma.
Observation:
- This rare tumor can manifest in the trunk, head and neck, internal organs, and soft tissues.
- IMT exhibits varied locations throughout the body.
Findings:
- The primary therapeutic approach for IMT involves complete surgical excision of the affected lesion.
- Surgical resection is the mainstay of IMT treatment.
Implications:
- Accurate diagnosis and complete surgical removal are crucial for managing IMT.
- Understanding the varied presentations of IMT aids in timely diagnosis and effective treatment.
